IDXX

SELL

IDEXX Laboratories, Inc.

Healthcare · Rank #138 · Analyzed Oct 18, 2026

$560.36

Current Price

$155.19

Intrinsic Value

-72.3%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 72.3%

Fair Value Range

Low$81.37

Base (IV)$155.19

High$210.43

Entry Points

Conservative$56.96

Moderate$81.37

Aggressive$108.64

Quality & Moat Breakdown

Return on Equity74.2% → 1.0/1.0

Debt LevelD/E 68 → 0/1.0

Revenue QualityGrowth 8.3%, margin Δ+5.1% → 1.0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins25.0% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.